Menu
GeneBe

OASL

2'-5'-oligoadenylate synthetase like, the group of 2'-5'-oligoadenylate synthetase family

Basic information

Region (hg38): 12:121017762-121039246

Links

ENSG00000135114NCBI:8638OMIM:603281HGNC:8090Uniprot:Q15646AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OASL gene.

  • Inborn genetic diseases (17 variants)
  • not provided (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OASL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
17
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 17 2 0

Variants in OASL

This is a list of pathogenic ClinVar variants found in the OASL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-121020620-C-T not specified Uncertain significance (Mar 14, 2023)2468255
12-121020746-T-C not specified Uncertain significance (Nov 29, 2023)3203675
12-121020794-C-T not specified Uncertain significance (Jun 05, 2023)2556549
12-121020797-A-C not specified Uncertain significance (Apr 13, 2023)2536895
12-121020880-C-G not specified Uncertain significance (Nov 03, 2022)2367928
12-121020955-C-T not specified Likely benign (Nov 22, 2023)3203674
12-121021051-C-T not specified Uncertain significance (Nov 08, 2022)3203673
12-121024001-A-G not specified Uncertain significance (May 01, 2022)2376209
12-121024100-C-T not specified Uncertain significance (Dec 13, 2023)3203682
12-121024104-G-A not specified Likely benign (Mar 01, 2024)3203681
12-121024131-G-C not specified Uncertain significance (May 24, 2023)2550889
12-121024136-G-A not specified Uncertain significance (Sep 06, 2022)2310452
12-121027638-C-G not specified Uncertain significance (Jan 09, 2024)3203680
12-121027706-C-T not specified Uncertain significance (Dec 17, 2023)3203679
12-121027736-C-G not specified Uncertain significance (May 27, 2022)2216910
12-121027774-T-C not specified Uncertain significance (Sep 01, 2021)2395594
12-121031467-C-T not specified Uncertain significance (Feb 23, 2023)2464735
12-121031493-C-A Likely benign (Apr 01, 2022)2643402
12-121031561-C-A not specified Uncertain significance (Nov 10, 2022)2325339
12-121031573-T-C not specified Uncertain significance (Jul 06, 2021)3203678
12-121033484-A-G not specified Uncertain significance (Oct 12, 2021)2365809
12-121033511-C-T not specified Likely benign (Sep 27, 2021)3203677
12-121033522-G-A Likely benign (Feb 01, 2023)2643403
12-121033523-A-G not specified Uncertain significance (Aug 10, 2021)2379792
12-121033538-G-C not specified Uncertain significance (May 10, 2023)2535569

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OASLprotein_codingprotein_codingENST00000257570 618951
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.76e-110.041812562801201257480.000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.06992852880.9880.00001583378
Missense in Polyphen7176.7060.92562954
Synonymous0.6271131220.9280.000007281013
Loss of Function-0.09921615.61.036.73e-7178

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007270.000727
Ashkenazi Jewish0.00009930.0000992
East Asian0.0008160.000816
Finnish0.00004650.0000462
European (Non-Finnish)0.0007150.000712
Middle Eastern0.0008160.000816
South Asian0.0001310.000131
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Does not have 2'-5'-OAS activity, but can bind double- stranded RNA. Displays antiviral activity against encephalomyocarditis virus (EMCV) and hepatitis C virus (HCV) via an alternative antiviral pathway independent of RNase L. {ECO:0000269|PubMed:18931074, ECO:0000269|PubMed:20074559, ECO:0000269|PubMed:9826176}.;
Pathway
Human papillomavirus infection - Homo sapiens (human);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling (Consensus)

Recessive Scores

pRec
0.107

Intolerance Scores

loftool
0.977
rvis_EVS
-0.4
rvis_percentile_EVS
26.93

Haploinsufficiency Scores

pHI
0.100
hipred
N
hipred_score
0.123
ghis
0.443

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0000192

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Oasl1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
response to virus;negative regulation of viral genome replication;defense response to virus;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;regulation of ribonuclease activity
Cellular component
nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;membrane
Molecular function
2'-5'-oligoadenylate synthetase activity;DNA binding;RNA binding;double-stranded RNA binding;ATP binding;thyroid hormone receptor binding